Mal-Deferoxamine is a maleamide (Mal)-containing Deferoxamine (HY-B1625). Mal selectively covalently binds to sulfur groups to produce a linking reaction. Mal-Deferoxamine can be combined with radionuclides to synthesize radionuclide drug conjugates (RDCs). RDCs have the ability to specifically target biomolecules and can be used in medical imaging or therapy.[1].
Molecular Weight:
711.80
Purity:
95
CAS Number:
[1638156-31-6]
Formula:
C32H53N7O11
Target:
Akt,Apoptosis,Autophagy,HIF/HIF Prolyl-Hydroxylase,Radionuclide-Drug Conjugates (RDCs),Reactive Oxygen Species (ROS)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
